I
ABBV icon

INVST’s AbbVie ABBV Stock Holding History

INVST’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$659K Sell
2,618
-860
-25% -$185K 0.06% 229
2026
Q1 		$757K Sell
3,478
-3,735
-52% -$829K 0.09% 197
2025
Q4 		$1.65M Sell
7,213
-130
-2% -$29.6K 0.18% 98
2025
Q3 		$1.7M Sell
7,343
-282
-4% -$57.4K 0.19% 93
2025
Q2 		$1.42M Buy
7,625
+1,171
+18% +$218K 0.18% 100
2025
Q1 		$1.35M Buy
6,454
+2,633
+69% +$512K 0.18% 97
2024
Q4 		$679K Sell
3,821
-79
-2% -$14.5K 0.08% 150
2024
Q3 		$770K Sell
3,900
-233
-6% -$43.5K 0.09% 142
2024
Q2 		$704K Buy
4,133
+774
+23% +$128K 0.08% 139
2024
Q1 		$607K Sell
3,359
-736
-18% -$127K 0.07% 148
2023
Q4 		$710K Buy
4,095
+162
+4% +$23.6K 0.09% 128
2023
Q3 		$586K Buy
3,933
+198
+5% +$29.1K 0.08% 140
2023
Q2 		$503K Buy
3,735
+21
+0.6% +$3.08K 0.07% 135
2023
Q1 		$553K Sell
3,714
-5,966
-62% -$912K 0.09% 127
2022
Q4 		$1.43M Sell
9,680
-693
-7% -$106K 0.22% 61
2022
Q3 		$1.44M Sell
10,373
-575
-5% -$82.5K 0.25% 53
2022
Q2 		$1.54M Buy
10,948
+1,132
+12% +$173K 0.24% 54
2022
Q1 		$1.48M Sell
9,816
-329
-3% -$47.8K 0.24% 57
2021
Q4 		$1.49M Buy
10,145
+123
+1% +$14.5K 0.23% 62
2021
Q3 		$1.08M Buy
10,022
+437
+5% +$49.9K 0.17% 74
2021
Q2 		$1.13M Buy
9,585
+88
+0.9% +$9.91K 0.18% 70
2021
Q1 		$1.06M Sell
9,497
-1,009
-10% -$108K 0.18% 70
2020
Q4 		$1.13M Buy
10,506
+1,862
+22% +$179K 0.2% 59
2020
Q3 		$753K Buy
8,644
+579
+7% +$54.5K 0.18% 62
2020
Q2 		$800K Buy
8,065
+938
+13% +$82.6K 0.24% 55
2020
Q1 		$523K Buy
+7,127
New +$607K 0.22% 56

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

INVST's ABBV Position: Q2 2026 in Review

INVST reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $185K and leaving 2,618 shares worth $659K. The position accounts for 0.06% of the portfolio, ranked #229.

INVST first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.7M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • INVST held 2,618 shares of AbbVie worth $659K as of Q2 2026.
  • INVST sold 860 AbbVie shares in Q2 2026, an estimated $185K.
  • AbbVie made up 0.06% of INVST's portfolio in Q2 2026, its #229 holding.
  • INVST first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • INVST's AbbVie position peaked at $1.7M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.